Netherlands· NL-796b28888bba

Aprepitant Sandoz 125 mg harde capsules

A aprepitant product containing aprepitant, registered in Netherlands by Sandoz B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC A04AD12

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about aprepitantAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Aprepitant is registered in 17 of 19 countries.

Countries holding a registration under ATC A04AD12 (aprepitant), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search aprepitant products by name

Aprepitant · ATC A04AD12

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of aprepitant costs, country by country.

Normalised to the WHO defined daily dose (165 mg), the median price runs from $0.40 in Finland to $157.48 in United States — a ×394 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Aprepitant · price per daily dose (165 mg)

USD · FX 28 Sept 2026

US United States$157.48 (acquisition cost)
CH Switzerland$73.26
FR France$33.15
FI Finland$0.40

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: APREPITANT
Manufacturer: Sandoz B.V.
Country: Netherlands (NL)
ATC code: A04AD12
ATC class: Aprepitant
Defined daily dose: 165 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
120490

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

583 interactions on record for aprepitant.

Graded by severity as the source publishes them — 73 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check aprepitant against other medicines How interaction checks work

Aprepitant · interactions on record

583 records

73 severe
380 moderate
25 minor
104 info

Most severe, free to view

CisaprideA03FA02severe
NaloxegolA06AH03severe
EliglustatA16AX10severe
LonafarnibA16AX20severe

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Aprepitant in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All aprepitant products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Aprepitant Accord, Aprepitant Ratiopharm
Belgium · Aprepitant Sandoz, Aprepitant Teva
Cyprus · Atanto, Endrem
Czechia · Aprepitant Accord, Aprepitant Sandoz
Germany · Aprepilor, Aprepitant Al
Denmark · Aprepitant "medical Valley", Aprepitant Medical Valley
Estonia · Aprepitant Sandoz
Spain · Aprepitant Accord, Aprepitant Qilu
Finland · Aprepitant Stada
France · Aprepitant Accord, Aprepitant Aprepitant
United Kingdom (Northern Ireland) · Aprepitant, Aprepitant Accord
Greece · Aprepitant Win Medica, Atanto
Croatia · Aprepitant Alpha-Medical, Aprepitant Sandoz
Hungary · Aprepitant Pharmacenter, Aprepitant Q Pharma
Ireland · Aprepitant Accord
Iceland · Aprepitant Medical Valley, Aprepitant Stada
Italy · Aprepitant Accord, Aprepitant Teva
Liechtenstein · Emend
Lithuania · Aprepitant Sandoz
Latvia · Aprepitant Sandoz
Norway · Emend
Poland · Aprepitant Accord, Aprepitant Sandoz
Portugal · Aprepitant Generis
Sweden · Aprepitant Medical Valley, Aprepitant Stada
Slovenia · Aprepitant Teva
Slovakia · Aprepitant, Aprepitant Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/dec80587-430e-478d-89b7-7a434b6beaa3
GET /v1/drugs/dec80587-430e-478d-89b7-7a434b6beaa3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h120490_smpc.pdf",
  "strength": null,
  "atc_label": "Aprepitant",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg120490",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "GELATINE (E 441)",
    "HYPROLOSE (E 463)",
    "IJZEROXIDE ROOD  (E 172)",
    "NATRIUMLAURILSULFAAT",
    "SACCHAROSE",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "APREPITANT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h120490.pdf",
  "authorised_at": "2018/04/24",
  "procedure_number": "HU/H/0498/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "120490",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about aprepitant.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console